Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Investigating the effect of Zinc-Sulfate on the Treatment of Neonatal Hyperbilirubinemia
IRCT20220806055625N1Phase 3Completed
- Sponsor
- Kurdistan University of Medical Sciences
- Start
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of zinc in neonatal hyperbilirubinemia, sponsored by Kurdistan University of Medical Sciences. Started Dec 2022; status: completed.
02
Drugs
zinc
03
Conditions
neonatal hyperbilirubinemia
Beyond the preview
Go deeper on IRCT20220806055625N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220806055625N1.